A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), ...

Obesity rates for Black children and adolescents are 22.4% in the decade before the pandemic and 35% in the 2 years after the ...

Referral to catheter ablation should not be delayed until the patient loses weight, say researchers for the PRAGUE-25 trial.

Uncover the psychophysiological roots of obesity in India to revolutionize interventions and combat the epidemic effectively.

Tirzepatide use vs placebo was associated with slower decline in eGFR among patients with prediabetes and obesity or ...

Discover how sarcopenic obesity affects 23% of people through hidden muscle loss and fat gain, plus treatment options.

Your bedroom lighting choices could be silently damaging your health every night. Research shows just one night of moderate ...

Protagonist is directly going up against Eli Lilly, which is advancing retatrutide, also a triple-G agonist, in a Phase II ...

A new healthy food standard has been announced by the Government with the hope that big businesses will promote healthier ...

Syntis Bio, Inc. (Syntis), a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes ...

A brief research report evaluated obesity among U.S. children and adolescents from 2011 to August 2023 and compared changes ...

CagriSema vs placebo was associated with significant weight loss among adults with overweight or obesity with or without type ...